Research programme: leucine/nicotinic acid - NuSirt BiopharmaAlternative Names: Leucine/niacin; Niacin/leucine; Nicotinic acid/leucine
Latest Information Update: 09 Jul 2015
At a glance
- Originator NuSirt Biopharma
- Class Branched-chain amino acids; Essential amino acids; Nicotinic-acids; Small molecules; Vitamins
- Mechanism of Action GPR109A receptor agonists; GPR109B receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Atherosclerosis; Hyperlipidaemia